eIF4AI/II (H-5) PE Antibody sc-377315 PE from Santa Cruz Biotechnology, Inc.

Product Specs
ItemeIF4AI/II (H-5) PE Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $343.00Supplier Page View Company Product Page
Catalog Numbersc-377315 PE
Antibody TypePrimary Antibody Conjugates
Clonalitymonoclonal
Reactivitymouse, rat, human
FormatPurified
ApplicationsWB(RGB), IF, IHC(P), FCM
CloneH-5
IsotypeIgG1
Hostmouse
Quantity200 µg/ml
TargeteIF4AI
NCBI Full Gene Nameeukaryotic translation initiation factor 4A1, eukaryotic translation initiation factor 4A2
NCBI Gene AliasesDdx2a, DDX2B, EIF4A, Eif4, DDX2A, eIF-4A-II, eIF4A-II, Ddx2b, EIF-4A, 4833432N07Rik, BM-010, EIF4F, eIF4A-I, eIF-4A-I
Conjugate/Tagphycoerythrin

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancerMolecular cancerJuly 29, 2023García-Vílchez R, Añazco-Guenkova AM, Dietmann S, López J, Morón-Calvente V, D'Ambrosi S, Nombela P, Zamacola K, Mendizabal I, García-Longarte S, et al.

(3) METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2Cell reportsMarch 28, 2023Wang F, Zhang J, Lin X, Yang L, Zhou Q, Mi X, Li Q, Wang S, Li D, Liu XM, et al.

(4) Targeting GRP78 suppresses oncogenic KRAS protein expression and reduces viability of cancer cells bearing various KRAS mutationsNeoplasia (New York, N.Y.)November 1, 2022Ha DP, Huang B, Wang H, Rangel DF, Van Krieken R, Liu Z, Samanta S, Neamati N, Lee AS.

(5) Novel eIF4A1 inhibitors with anti-tumor activity in lymphomaMolecular medicine (Cambridge, Mass.)September 4, 2022Kayastha F, Herrington NB, Kapadia B, Roychowdhury A, Nanaji N, Kellogg GE, Gartenhaus RB.

(6) PARK2 regulates eIF4B-driven lymphomagenesisMolecular cancer research : MCRFebruary 1, 2022Kapadia BB, Roychowdhury A, Kayastha F, Nanaji N, Gartenhaus RB.

(7) In situ detection of the eIF4F translation initiation complex in mammalian cells and tissuesSTAR protocolsSeptember 17, 2021Shen S, Girault I, Malka-Mahieu H, Robert C, Vagner S.

(8) Dual targeting of DDX3 and eIF4A by the translation inhibitor rocaglamide ACell chemical biologyApril 15, 2021Chen M, Asanuma M, Takahashi M, Shichino Y, Mito M, Fujiwara K, Saito H, Floor SN, Ingolia NT, Sodeoka M, et al.

(11) The Interactome analysis of the Respiratory Syncytial Virus protein M2-1 suggests a new role in viral mRNA metabolism post-transcriptionScientific reportsOctober 24, 2019Bouillier C, Cosentino G, Léger T, Rincheval V, Richard CA, Desquesnes A, Sitterlin D, Blouquit-Laye S, Eléouët JF, Gault E, et al.

(14) Decreased abundance of eIF4F subunits predisposes low birth weight neonatal pigs to reduced muscle hypertrophyJournal of applied physiology (Bethesda, Md. : 1985)October 1, 2018El-Kadi SW, Chen Y, McCauley SR, Seymour KA, Johnson SE, Rhoads RP.

(15) Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCLNature communicationsFebruary 26, 2018Kapadia B, Nanaji NM, Bhalla K, Bhandary B, Lapidus R, Beheshti A, Evens AM, Gartenhaus RB.

(16) High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and BodiesMolecular cellFebruary 1, 2018Youn JY, Dunham WH, Hong SJ, Knight JDR, Bashkurov M, Chen GI, Bagci H, Rathod B, MacLeod G, Eng SWM, et al.

(17) Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1Nature communicationsDecember 20, 2017Wang J, Ye Q, Cao Y, Guo Y, Huang X, Mi W, Liu S, Wang C, Yang HS, Zhou BP, et al.

eIF4AI/II (H-5) PE Antibody